Get the latest delivered to your inbox
Privacy Policy

Now Reading

Global Business Coalition on HIV/AIDS (GBC) Applauds Bristol-Myers Squibb's New Commitment to its HIV/AIDS Programs in Africa

Global Business Coalition on HIV/AIDS (GBC) Applauds Bristol-Myers Squibb's New Commitment to its HIV/AIDS Programs in Africa

Published 06-27-05

Submitted by GBCHealth

New York - The Global Business Coalition on HIV/AIDS (GBC) applauds the joint program of member company Bristol-Myers Squibb and Baylor College of Medicine that will provide medical care for African children with HIV/AIDS. Under the multi-part program, a pediatric AIDS corps will be created to send up to 250 doctors to Africa to treat approximately 80,000 children over five years and to train local health care professionals. In addition, the $40 million program will provide funding for four new children's clinical centers of excellence. Bristol-Myers Squibb has agreed to commit approximately $30 million, while Baylor College of Medicine will commit $10 million.

The new program is the latest addition to Bristol-Myers Squibb's SECURE THE FUTURE initiative which has already made 200 grants totaling $120 million in sub-Saharan Africa, and Baylor College of Medicine's International Pediatric AIDS Initiative, which built and operates several of the world's largest pediatric HIV/AIDS treatment centers in developing countries in Africa and Eastern Europe.

Bristol-Myers Squibb also announced that it is reducing the price of pediatric formulations of HIV medicines in the world's least developed countries to expand access to treatment.

"By leading the efforts in supporting the world's most vulnerable population, Bristol-Myers Squibb continues to show strong commitment to this critical public health issue," said GBC Executive Director Trevor Neilson. "Pediatric AIDS medicines are vital in providing a future for over 2 million children currently infected with HIV/AIDS."

About the Global Business Coalition on HIV/AIDS (GBC)

The Global Business Coalition on HIV/AIDS (GBC) is the pre-eminent organization leading the business fight against HIV/AIDS. The rapidly-expanding alliance of 200 international companies is dedicated to combating the AIDS epidemic through the business sector's unique skills and expertise. The mission of the GBC is to harness the power of the global business community to end the HIV/AIDS pandemic. For more information, please visit the GBC website at www.businessfightsaids.org, the leading global resource of company AIDS programs and hub of information relevant to business concerned about AIDS.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Contact:
Becky Taylor
Bristol-Myers Squibb
Cell: 609-240-5134
Office: 609-252-4476
rebecca.taylor@bms.com

Visit Bristol-Myers Squibb on the World Wide Web at: www.bms.com
Visit SECURE THE FUTURE on the World Wide Web at: www.securethefuture.com

About Baylor College of Medicine

Baylor College of Medicine, one of the nation's top academic health sciences centers, is committed to advancing human health through the integration of patient care, research, education and community service.

Contact:
Lori Williams
Baylor College of Medicine
Cell: 713-775-6912
Office: 713-798-4712
loriw@bcm.tmc.edu

Visit Baylor College of Medicine International Pediatric AIDS Initiative at: www.bayloraids.org

GBCHealth Logo

GBCHealth

GBCHealth

GBCHealth is the preeminent organization focused on business engagement in support of meeting global goals for health. Its vision is health equity and a global business community that contributes its assets, skills, influence and reach to create a healthier world for employees, their families, and communities. GBCHealth works with companies worldwide and with the United Nations, governments, academia, civil society & others. In September 2022, GBCHealth launched future united, a global initiative harnessing the power of the private sector to fight for - and achieve - health equity, tackle the impact of climate change on health, and address antimicrobial resistance and future pandemics.

More from GBCHealth

Join today and get the latest delivered to your inbox